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agement of SM. The IGP is a practical method for reaching
consensus involving complicated decision processes such
as SM.
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COST-EFFECTIVENESS OF FIVE ORAL 
ANTIMICROBIALS FOR ACUTE OTITIS MEDIA
Kaplan-Machlis B1, Wandstrat TL2, Beane JS1
1West Virginia University, School of Pharmacy, Charleston, 
WV, USA; 2Novartis Pharmaceuticals, Inc., East Hanover, NJ, 
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OBJECTIVES: To compare direct and indirect costs of
treating acute otitis media (AOM) using five antimicrobials. 
METHODS: In this study 263 patients, mean age 35.2
months (SD 23.0), were enrolled from six primary care
clinics in a prospective, randomized, naturalistic cost-
effectiveness trial. Inclusion criteria were age 6 months
and 8 years, clinical diagnosis of AOM, physician re-
quiring antimicrobial treatment, and no antimicrobial re-
ceived within 30 days. Patients with allergies to the study
antimicrobials were excluded. Direct costs included phy-
sician, clinic, laboratory, procedure charges, antimicrobi-
als, ancillary medications, side effects, and revisits. Indi-
rect costs included travel, loss of parental income, and
baby-sitter fees. After giving informed consent, patients
were randomized to amoxicillin (N  53), amoxicillin/
clavulanate (N  52), azithromycin (N  60), clarithro-
mycin (N  48), or cefixime (N  50) treatment and fol-
lowed for 30 days. Biweekly telephone surveys of patient
caregivers and chart reviews were used to collect resource
utilization data. 
RESULTS: Total cost of treatment was lowest with
azithromycin, $130.85 (SD 79.50), and highest with ce-
fixime, $180.69 (SD 90.48), p  0.081. Statistically signif-
icant differences among antimicrobial costs were observed;
lowest mean cost was amoxicillin, $5.71 (SD 1.50) and
highest was cefixime, $63.56 (SD 8.12), p  0.0001. Al-
though not statistically significant, total direct costs of
treatment were lower with azithromycin, $81.12 (SD
43.67) than amoxicillin, $94.32 (SD 59.43), p  0.69. 
CONCLUSIONS: Statistically significant differences in
total costs between antimicrobials in treating AOM were
not observed.
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THE RATE OF INFECTIONS CONCURRENT 
WITH INTRAVENOUS PATIENT-CONTROLLED 
ANALGESIA
Shmuely Y, Lydick E
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OBJECTIVE: To evaluate the rate of infections concur-
rent with morphine intravenous patient-controlled anal-
gesia (PCA) and estimate the costs that are associated
with these infections (such as length of stay and hospital
charges). 
METHODS: This database study sample included 27,737
hospital patients greater than 6 years old, from hospital-
ized patients who were discharged during October 1995
through September 1996 from a sample of 59 US hospi-
tals. Line-related infection was defined as Staphylococcal
septicimia, the most common form of line-related infec-
tion. Patients with a primary diagnosis of staphylococcus
septicemia were removed prior to analysis. 
RESULTS: The rate of infections among morphine IV
PCA users in was 0.5% (140/27,737). Patients with in-
fections have a statistically significant higher death rate
(25.1%) than patients without line-related infections
(8.9%). Moreover, patients with infections had statisti-
cally significantly longer median length of stay in the hos-
pital (22.5 days) than patients without line-related infec-
tions (8 days). Consequently, median hospital charge for
patients with line-related infections is statistically signifi-
cantly higher ($53,130.57) than for patients without line-
related infections ($18,981.43). A nested case-control com-
parison whereby patients with infections were matched to
controls based on age, gender, and primary diagnosis, pro-
duced similar results. 
CONCLUSION: Line-related infections add substantially
to the cost of care, compared with costs for uninfected
patients.
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Antitetanus prophylaxis (ATP) is based on the WHO rec-
ommendations that cause overprescribing of tetanus im-
munoglobulins (TIg) in over 40% of cases. An interven-
tion to reduce prescribing of unwarranted TIg was
conducted.
METHODS: The intervention combined locally devel-
oped guidelines (LDG) to a 4-month teaching program.
Before the intervention: 1) TIg prescribed for patients
with open wounds were retrospectively collected during
66 months (I  66), 2) ATP delivered according to WHO
guidelines was prospectively studied in consecutive pa-
tients with open wounds during the month preceding the
intervention. After the intervention we prospectively
studied: 1) ATP according to LDG during the month fol-
lowing the intervention, 2) then TIg prescribed during 26
months afterwards (I  26).
RESULTS: The intervention took place between June
and September 1995. The number of patients with open
wounds increased from 6933 in 1990 to 7922 in 1997.
TIg prescribed to them decreased from 60% at (I  66)
to 23% of 389 consecutive patients prospectively studied
1 month before the intervention, to 1% (p  10–3) of
459 consecutive patients observed 1 month thereafter.
The reduction of TIg prescribing was maintained below
